148 related articles for article (PubMed ID: 32415394)
1. [The long journey from palpation to biopsy : The history of diagnosing prostate cancer].
Konert J; Sentker L; August C; Hatzinger M
Urologe A; 2021 Jul; 60(7):943-949. PubMed ID: 32415394
[TBL] [Abstract][Full Text] [Related]
2. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.
Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R
Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.
Ellis WJ; Chetner MP; Preston SD; Brawer MK
J Urol; 1994 Nov; 152(5 Pt 1):1520-5. PubMed ID: 7523710
[TBL] [Abstract][Full Text] [Related]
6. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.
Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 1994 May; 151(5):1283-90. PubMed ID: 7512659
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic algorithm based on a multivariate model to reduce the percentage of negative prostatic biopsies in patients with changed PSA or suspicious rectal palpation].
Valer Algarabel J; Agüera Fernández L; Adot Zurbano JM; Virseda Chamorro M; Marcos Díez J; Gómez López A; Alpuente Román C
Actas Urol Esp; 2000; 24(7):549-59. PubMed ID: 11011445
[TBL] [Abstract][Full Text] [Related]
8. Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination.
Miotto A; Srougi M; Brito GA; Leite KM; Nesrallah AJ; Ortiz V
Int Braz J Urol; 2004; 30(2):109-13. PubMed ID: 15703091
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer detection at low prostate specific antigen.
Schröder FH; van der Cruijsen-Koeter I; de Koning HJ; Vis AN; Hoedemaeker RF; Kranse R
J Urol; 2000 Mar; 163(3):806-12. PubMed ID: 10687982
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies.
Huland H; Hammerer P; Henke RP; Huland E
J Urol; 1996 Apr; 155(4):1344-7. PubMed ID: 8632570
[TBL] [Abstract][Full Text] [Related]
12. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H;
Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
[TBL] [Abstract][Full Text] [Related]
13. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
14. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
[TBL] [Abstract][Full Text] [Related]
15. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
16. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
Presti JC; Hovey R; Carroll PR; Shinohara K
J Urol; 1996 Nov; 156(5):1685-90. PubMed ID: 8863571
[TBL] [Abstract][Full Text] [Related]
18. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.
Ornstein DK; Rao GS; Smith DS; Ratliff TL; Basler JW; Catalona WJ
J Urol; 1997 Jan; 157(1):195-8. PubMed ID: 8976249
[TBL] [Abstract][Full Text] [Related]
19. PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience.
Ramos CG; Valdevenito R; Vergara I; Anabalon P; Sanchez C; Fulla J
Urol Oncol; 2013 Nov; 31(8):1522-6. PubMed ID: 22687565
[TBL] [Abstract][Full Text] [Related]
20. A comparison of magnetic resonance imaging techniques used to secure biopsies in prostate cancer patients.
van Luijtelaar A; Bomers J; Fütterer J
Expert Rev Anticancer Ther; 2019 Aug; 19(8):705-716. PubMed ID: 31277551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
